- Home
- GPRO vs XBIT Comparison
GPRO vs XBIT Comparison
Compare GPRO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- XBIT
- Stock Information
- Founded
- GPRO 2004
- XBIT 2005
- Country
- GPRO United States
- XBIT United States
- Employees
- GPRO 696
- XBIT N/A
- Industry
- GPRO Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- GPRO Consumer Discretionary
- XBIT Health Care
- Exchange
- GPRO Nasdaq
- XBIT Nasdaq
- Market Cap
- GPRO 118.4M
- XBIT 89.6M
- IPO Year
- GPRO 2014
- XBIT 2015
- Fundamental
- Price
- GPRO $0.74
- XBIT $3.18
- Analyst Decision
- GPRO Hold
- XBIT
- Analyst Count
- GPRO 1
- XBIT 0
- Target Price
- GPRO $1.50
- XBIT N/A
- AVG Volume (30 Days)
- GPRO 5.2M
- XBIT 187.9K
- Earning Date
- GPRO 08-05-2025
- XBIT 08-11-2025
- Dividend Yield
- GPRO N/A
- XBIT N/A
- EPS Growth
- GPRO N/A
- XBIT N/A
- EPS
- GPRO N/A
- XBIT N/A
- Revenue
- GPRO $780,312,000.00
- XBIT N/A
- Revenue This Year
- GPRO N/A
- XBIT N/A
- Revenue Next Year
- GPRO $6.79
- XBIT N/A
- P/E Ratio
- GPRO N/A
- XBIT N/A
- Revenue Growth
- GPRO N/A
- XBIT N/A
- 52 Week Low
- GPRO $0.40
- XBIT $2.50
- 52 Week High
- GPRO $1.76
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- GPRO 47.74
- XBIT 63.47
- Support Level
- GPRO $0.67
- XBIT $2.58
- Resistance Level
- GPRO $0.95
- XBIT $3.32
- Average True Range (ATR)
- GPRO 0.06
- XBIT 0.17
- MACD
- GPRO -0.02
- XBIT 0.07
- Stochastic Oscillator
- GPRO 26.26
- XBIT 82.93
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.